Skip to main content

Table 1 Patient characteristics at the start of first-line chemoradiotherapy

From: Efficacy of platinum agents for stage III non-small-cell lung cancer following platinum-based chemoradiotherapy: a retrospective study

Characteristics

Platinum group

non-Platinum group

P-value

n

%

n

%

Overall

119

 

201

  

Age (years)

 Median (range)

63

(33—81)

65

(44—80)

 

  ≥ 75

8

6.7

15

7.5

1.0

  < 75

111

93.3

186

92.5

Sex

 Female

18

15.1

25

12.4

0.50

 Male

101

84.9

176

87.6

Smoking status

 Current

68

57.1

115

57.2

1.0

 Former

44

37.0

75

37.3

 Never

7

5.9

11

5.5

Respiratory comorbidity

 Yes

43

36.1

78

38.8

0.72

 No

76

63.9

123

61.2

ECOG PS

 0

66

55.5

100

49.8

0.41

 1

49

41.2

97

48.3

 2

4

3.4

4

2.0

Histology

 Adenocarcinoma

51

42.9

85

42.3

0.99

 Squamous cell carcinoma

53

44.5

89

44.3

 Other

15

12.6

27

13.4

Clinical stage (UICC-TNM classification, 7th edition)

 IIIA

60

50.4

95

47.3

0.64

 IIIB

59

49.6

106

52.7

  1. ECOG PS Eastern Cooperative Oncology Group performance status, UICC Union for International Cancer Control
  2. All P values were calculated using the Fisher’s exact test